Six Former and Current Novartis AG Execs Charged With Bribing Doctors in Korea | BioSpace
AGC Biologics to buy Novartis facility in Longmont – Colorado Hometown Weekly
Novartis chief fights to restore faith - SWI swissinfo.ch
Cause and Effect | SIX
Novartis Q1 earnings drop as cancer drug sales falter | Pharmafile
NOVN: Novartis AG Stock Price Quote - SIX Swiss Ex - Bloomberg
Drug used to treat advanced prostate cancer in short supply, Novartis says - CBS News
It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement. - The New York Times
Novartis pays $100M for Mallinckrodt's priority review voucher
Novartis CEO Targets 20 Key Drugs as Potential Blockbusters - DCAT Value Chain Insights
NOVN: Novartis AG Stock Price Quote - SIX Swiss Ex - Bloomberg
Novartis sells phase 3 rare disease drug to Pharming | Fierce Biotech
Two Children Die After Receiving Novartis Gene Therapy | The Scientist Magazine®
Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer
Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026 | BioSpace
BioCentury - Marti leaving Novartis Oncology legal team
Novartis' $3B prospect beats AstraZeneca blockbuster in phase 3
HazardEx - Novartis plant leak causes hospitalisation of six workers